The brainless jock stereotype is long gone, writes Ben Bryant. Long live the new gym bro, fuelled by a love of gains and a ...

Graduating from college is an exciting milestone, but it also marks the beginning of serious financial responsibility. As graduates step into this next chapter, laying a strong financial foundation is ...

Parex Resources Inc. ("Parex" or the "Company") is pleased to announce its financial and operating results for the three-month period ended March 31, 2025, the declaration of its Q2 2025 regular ...

Back in the day, entrepreneurs kept far away from government and policy, but today it's becoming common to go from business ...

Enbridge's natural gas utilities helped it during Q1, but they will not be as helpful over the next few quarters. Read why ...

Blue-chip high-yield stocks are popular for passive income and strong returns, but some now face growing risks. Learn more on ...

Researchers at the Manchester Institute of Biotechnology (MIB) have demonstrated how genetically engineered enzymes can ...

A Chicago-born cardinal walks into a conclave. The rest of the joke tells itself. In the breathless day since Pope Leo XIV’s ...

VERAXA Biotech AG ("VERAXA"), an emerging leader in designing novel cancer therapies and proposed de-SPAC acquisition target of Voyager Acquisition ...

Company announcement - No. 12 / 2025 Zealand Pharma announces closing of collaboration and license agreement with Roche Copenhagen, Denmark, May 9, 2025 - Zealand Pharma A/S ("the Company" or "Zealand ...